RULE 10B5-1 SALES PLANRule 10b5-1 Sales Plan • June 24th, 2011 • Talon Therapeutics, Inc. • Pharmaceutical preparations
This Rule 10b-5-1 Sales Plan, dated June 13, 2011 (this “Sales Plan”) is made by and between UBS Securities, LLC (“Broker”), Deerfield Management Company, L.P., Series C, a Delaware limited partnership (the “Investment Manager”) and the following parties (each a “Stockholder” and together the “Stockholders”): Deerfield Private Design Fund, L.P., a Delaware limited partnership, Deerfield Private Design International, L.P. a British Virgin Islands limited partnership, Deerfield Special Situation Fund, L.P., a Delaware limited partnership, and Deerfield Special Situations Fund International Limited, a British Virgin Islands corporation.
